BRIEF published on 01/06/2025 at 18:02, 1 year 2 months ago Half-yearly liquidity contract report for OKWIND Group Liquidity Contract PORTZAMPARC BNP Paribas Semester 2024 OKWIND Group
BRIEF published on 11/04/2024 at 17:50, 1 year 4 months ago OKWIND Group: Share Buyback Program Review Common Shares Share Buyback Euronext Growth Stock Market Transactions OKWIND Group
BRIEF published on 10/30/2024 at 17:50, 1 year 4 months ago OKWIND GROUP: Share Buyback Program Share Buyback Financial Transactions Euronext Growth Own Shares OKWIND Group
BRIEF published on 10/16/2024 at 20:14, 1 year 5 months ago Groupe OKWIND Prepares for New Growth Cycle Amidst Challenges Financial Performance Market Strategy Revenue Decline Production Expansion Strategic Repositioning
PRESS RELEASE published on 10/16/2024 at 20:09, 1 year 5 months ago Inside Information / News release on accounts, results Groupe OKWIND reports H1 2024 results, outlines Q3 performance & adjusts 2024 targets. Expands offerings towards multi-technology solutions. Expecting growth in sales momentum and revenue in 4th quarter 2024 Targets H1 2024 Results Q3 Performance Groupe OKWIND Multi-technology Solutions
Published on 03/26/2026 at 21:00, 17 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 17 minutes ago Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 16:20, 4 hours 57 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 8 hours 17 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 20:48, 29 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 1 hour 57 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 2 hours 7 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 07:30, 13 hours 47 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
